Fig. 1From: Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional studyProportion of end-of-life respiratory modalities among patients dying with ILD. COT, conventional oxygen therapy; HFNC, high-flow nasal cannula; ILD, interstitial lung disease; IMV, invasive mechanical ventilation; NIV, non-invasive ventilationBack to article page